Home |
Recent Posts | Pages
Tag Archives: Athersys
-
Angiotech Pharma sells Lifespan vascular graft business for $2.8M Nov 19, 2010
-
Analyst: Stroke most promising use of Athersys’ MultiStem Nov 18, 2010
-
Athersys to begin clinical trial with Pfizer; loses $3.7M in Q3 Nov 8, 2010
-
Former shareholders sue Angiotech Pharma for lying Oct 7, 2010
-
Athersys CEO elected chair of regenerative medicine trade group Oct 7, 2010
-
Angiotech Pharmaceuticals struggles to reduce debt Oct 4, 2010
-
In-vitro fertilization pioneer wins Nobel Prize (Morning Read) Oct 4, 2010
-
Athersys reports more positive results from heart attack study Sep 23, 2010
-
Athersys stem cells get orphan drug status for bone marrow disease Sep 21, 2010
-
Athersys stem cell therapy promises to treat brain injury Sep 20, 2010
-
Athersys CEO downplays effect of lorcaserin decision Sep 17, 2010
-
Athersys licenses stem cell technology in deal worth up to $40M Sep 13, 2010
-
Athersys board member resigns Sep 10, 2010
-
Athersys shares fall on judge’s stem cell decision Aug 24, 2010
-
Power of Athersys stem cells may be underestimated, analyst says Aug 10, 2010
-
Athersys repeats good heart attack study results; reports 2Q loss Aug 9, 2010
-
Athersys stem cell therapy could offer new heart attack treatment Jul 28, 2010
-
Ohio Third Frontier Commission awards $14M in biomedical grants Jun 23, 2010
-
Experts laud potential of Athersys stem cell therapy MultiStem May 15, 2010
-
Athersys still excited about Pfizer stem cell collaboration May 6, 2010
-
Athersys executives excited about stem cell, drug programs Mar 11, 2010
-
OrbiMed Advisors raises $550M for health venture fund Feb 22, 2010
-
Athersys finishes enrolling heart attack patients for stem cell therapy study Feb 16, 2010
-
Athersys gets U.S., European patents for investigational stem cell therapy Feb 10, 2010
-
Biopharmaceutical company Athersys seeks to register 20 million shares, warrants for future sale Jan 14, 2010
Home |
Recent Posts | Pages
